Fatty acid amide hydrolase (FAAH) is a serine hydrolase with a prominent role in the hydrolysis of endocannabinoids. As such, it is a target for the development of inhibitors, with potential therapeutic roles in the treatment of chronic pain, inflammation, depression and eating disorders.






